Patent application number | Description | Published |
20110213125 | Humanized Antibodies Against Human Interferon-Alpha - The present invention provides humanized anti-human IFN-α monoclonal antibodies useful for therapeutic applications in humans. Preferred antibodies are humanized versions of murine antibodies ACO-1 and ACO-2, as well as variants thereof. | 09-01-2011 |
20120195888 | Humanized Antibodies Against Human Interferon-Alpha - The present invention provides humanized anti-human IFN-α monoclonal antibodies useful for therapeutic applications in humans. Preferred antibodies are humanized versions of murine antibodies ACO-1 and ACO-2, as well as variants thereof. | 08-02-2012 |
20130101602 | Humanized Antibodies Against Human Interferon-Alpha - The present invention provides humanized anti-human IFN-α monoclonal antibodies useful for therapeutic applications in humans. Preferred antibodies are humanized versions of murine antibodies ACO-1 and ACO-2, as well as variants thereof. | 04-25-2013 |
20130164299 | LLT-1 ANTIBODIES WITH NEW FUNCTIONAL PROPERTIES - The present invention relates to monoclonal antibodies that are capable of specifically binding to lectin-like transcript 1 (LLT1), to polynucleotides encoding such antibodies and to cells that express such antibodies. Antibodies of the invention have utility in the treatment of autoimmune diseases and cancer, in which LLT1- and CD161-expressing cells play a role in disease pathogenesis. | 06-27-2013 |
20130330360 | ANTAGONISTIC DR3 LIGANDS - The present disclosure relates to treatment of inflammatory diseases. In particular, the present disclosure relates to antagonistic DR | 12-12-2013 |
20130336984 | ANTAGONISTIC DR3 LIGANDS - The present invention relates to treatment of inflammatory diseases. In particular, the present invention relates to antagonistic DR3 ligands useful for treating inflammatory diseases. | 12-19-2013 |
20140294853 | ANTAGONISTIC DR3 LIGANDS - The present invention relates to treatment of inflammatory diseases. In particular, the present invention relates to antagonistic DR3 ligands useful for treating inflammatory diseases. | 10-02-2014 |
Patent application number | Description | Published |
20130206729 | SWITCH UNIT WITH ARC-EXTINGUISHING UNITS - A switch suitable for DC applications includes: two fixed conductive contacts with first contact areas; a movable conductive bridge with two second contact areas for being connected to the two first contact areas in the on-status and for being disconnected from the two the first contact areas in the off-status; and two arc-extinguishing units configured to extinguish electric arcs occurring between the first and second contact areas after disconnecting the second contact areas from the first contact areas. First conductive arc-guiding elements extend from each first contact area into the corresponding arc-extinguishing unit and at least one second conductive arc-guiding element extends into the arc-extinguishing units suitably shaped to guide the electric arcs from each of the second contact areas of the movable bridge into the arc-extinguishing units. | 08-15-2013 |
20130264310 | SWITCH HAVING A QUENCHING CHAMBER - A switch for polarity-independent multi-pole direct current operation includes at least two switching chambers. Each switching chamber includes a single circuit breaker with a stationary contact having a first contact region and a movable electrically conductive contact part having a second contact region. The stationary contact and movable contact part are configured to create a connection between the first and the second contact regions in the ON state and to disconnect the first and the second contact regions in the OFF state. Each chamber also includes two arc chutes for quenching an arc forming between the first and the second contact regions when switching to the OFF state. At least two magnets are configured to generate a magnetic field so as to exert a magnetic force on the arcs to divert each are in a direction of an arc chute independent of the direction of current. | 10-10-2013 |
20130264311 | SWITCH WITH QUENCHING CHAMBER - A switch for multi-pole direct current service independent of polarity includes a plurality of switching chambers. Each chamber includes a double interrupter having two separate fixed contacts with a first contact area, a movable contact piece with two second contact areas, each for creating a connection between the contact areas in an ON state and for separating the contact areas in an OFF state, and at least two quenching devices for quenching arcs occurring, when the OFF state is brought about. The switch also includes magnets for exerting a magnetic field in an area of the contact areas to exert a magnetic force on the arcs and drive the arcs, independent of their current direction, in the direction of one of the erasing devices. The contact pieces are disposed with the second contact areas essentially in a line perpendicular to a direction of motion of the arcs. | 10-10-2013 |
20130313228 | SWITCH WITH QUENCHING CHAMBER - A switch for polarity-independent direct current operation includes fixed contacts, each including a first contact area. A movable bridge contact with second contact areas is configured to form an electrically conducting connection between the contact areas in an ON state and to separate the contact areas in an OFF state. A magnetic field exerts a magnetic force on an arc occurring between the contact areas when the OFF state is generated. Quenching chambers are provided to quench arcs with a first current direction. A first arc deflector plate extends from each of the quenching chambers toward the first contact area and a second arc deflector plate extends toward the second contact area for removing the arc into the quenching chambers. Each movable bridge contact includes two bridge plates which extend around each of the first contact areas so as to quench arcs in a second direction. | 11-28-2013 |